NCT02786810View on ClinicalTrials.gov

Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

March 31, 2016

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Urinary Tract InfectionVesicoureteral Reflux
Interventions
DRUG

Sulfur hexafluoride type-a lipid microspheres

Used as a contrast to enhance renal ultrasound

Trial Locations (1)

38013

University of Tennessee Health Science Center, Memphis

All Listed Sponsors
lead

University of Tennessee

OTHER

NCT02786810 - Contrast Enhanced Ultrasound for Evaluation of Reflux Nephropathy | Biotech Hunter | Biotech Hunter